The United Kingdom collagen market was valued at USD 583.61 Million in 2025. It is poised to grow at a CAGR of 6.78% during the forecast period of 2026-2035, and reach USD 1124.66 Million by 2035. The market growth is expanding as nutraceutical innovation accelerates, clean-label collagen gains traction, and marine-derived formulations advance through focused research and development. Growing clinical validation in skin health and joint care heightens consumer confidence, while regulatory clarity and rising demand in sports nutrition and beauty-from-within categories support robust growth during the forecast period.
Base Year
Historical Period
Forecast Period
In May 2025, Darling Ingredients and Tessenderlo Group announced a joint venture, Nextida, combining collagen production capabilities. This consolidation is expected to boost operational efficiency and drive significant growth in the market.
One of the major market trends includes the approval of advanced collagen-based regenerative products. For instance, in July 2024, Geistlich received MDR certification for Chondro-Gide®, a collagen membrane used for cartilage regeneration in orthopedics.
The market is expanding, driven by rising demand in bone, joint, and cosmetic applications, with key market players accelerating growth through product innovation, strategic distribution, and increased consumer awareness.
Compound Annual Growth Rate
6.78%
Value in USD Million
2026-2035
*this image is indicative*
Collagen has become a key focus as consumers pursue proactive wellness routines that emphasize longevity, skin nourishment, and joint support. The market was valued at USD 583.61 Million in 2025, and is growing due to strong scientific validation, premium formulations, and an expanding preference for clean-label, ethically sourced ingredients. Increasing collaboration between nutrition brands and clinical research institutions drives product differentiation, while e-commerce and specialty retailers broaden accessibility. Growing interest in personalized supplementation and environmentally responsible production continues to strengthen the country’s collagen landscape.
Rising Demand for Plant-Based Collagen to Fuel Growth in the Market
The growing consumer preference for plant-based and ethically sourced supplements is a key driver of the market. In July 2025, Becura launched Glycura Veg with Vegcol Carnosine Infused Collagen, a plant-based product designed to combat glycation and support skin elasticity, hydration, and firmness. This launch highlights the increasing demand for vegan-friendly collagen solutions that combine efficacy with sustainability. As awareness of plant-based nutrition and anti-aging benefits continues to rise, the market is expected to experience significant growth, driven by both health-conscious and ethically minded consumers.
Some of the notable trends in the market include the expansion of xenograft collagen portfolios and the increasing demand for physician-dispensed collagen skincare.
Strategic Acquisitions are Likely to Boost the Market Expansion
The market is witnessing significant growth driven by strategic acquisitions and portfolio expansions in regenerative medicine. In October 2024, RTI Surgical, a London-based regenerative medicine-focused CDMO and portfolio company of Montagu Private Equity, acquired Collagen Solutions, a specialist in bovine and porcine biomaterials. This acquisition enhances RTI’s xenograft tissue offerings and strengthens its capabilities in cardiac, orthopaedic, sports medicine, and reconstructive applications. By enabling the development of innovative biomaterials and collaborative solutions with OEMs, such strategic moves are expected to boost the overall market presence and accelerate growth in the UK collagen sector.
Rising Demand for Physician-Dispensed Collagen Skincare to Strengthen the United Kingdom Collagen Market Value
The growing consumer preference for scientifically backed peri-procedure skincare products that support skin rejuvenation and collagen restoration is a growing trend shaping the market. In October 2023, Galderma announced the launch of its premium brand, Alastin Skincare®, in the UK, following its successful expansion in North America and Mexico. Alastin’s innovative formulations, featuring proprietary TriHex Technology®, cater to pre- and post-aesthetic procedures, enhancing skin health and promoting collagen renewal. This strategic entry underscores the rising adoption of physician-dispensed collagen products and is expected to accelerate the market’s growth in the coming years
Market Breakup by Source Market Breakup by Product Market Breakup by Application
Bovine is Poised to Lead the Market Share by Source
The market is segmented based on source into bovine, porcine, poultry, marine, and others. Among these, bovine‑derived collagen is expected to lead, holding a historical market share of nearly 35%. Its prominence is driven by wide availability, cost‑effectiveness, and versatility across nutraceuticals, cosmetics, and medical uses. Although marine, porcine, and poultry sources are gaining attention for niche applications, bovine collagen remains the backbone of the market due to its reliable supply and multifunctional benefits. Continued demand for accessible and adaptable collagen ingredients ensures its leading position for the foreseeable future.
The key features of the market report comprise strategic initiatives by the leading players. The major companies in the market are as follows: STERLING Biotech, through its Sterling Gelatin division, is a key participant in the collagen-based ingredients market. The company specializes in producing high-purity gelatin derived from collagen sourced primarily from bovine and porcine materials. Its portfolio includes pharmaceutical-, nutraceutical-, and food-grade gelatin, along with Di-Calcium Phosphate used in nutritional and healthcare formulations. With a precision-driven manufacturing process and strict quality standards, STERLING Biotech supports diverse applications in supplements, food processing, and therapeutics, reinforcing its relevance in the broader collagen market. Weishardt Holding SA is a prominent global supplier in the collagen industry, offering its advanced Naticol® range of naturally sourced marine collagen peptides. The company provides high-quality collagen ingredients for dietary supplements, functional foods and beverages, and pharmaceutical formulations. Naticol® is widely used for skin health, joint support, and overall wellness, supported by extensive clinical research. Through its expertise in gentle enzymatic processing and versatile product integration, Weishardt actively strengthens its presence in the collagen market, delivering scientifically validated solutions for health-focused brands. Advanced BioMatrix, Inc. is a biotechnology company specializing in high-quality extracellular matrix and collagen products for research and tissue engineering. The company offers Type III Collagen Solution, isolated from human placenta, containing approximately 85% Type III and 15% Type I collagen, provided as a sterile, ready-to-use solution. This product supports cell attachment, proliferation, and tissue culture applications, serving as a substrate scaffold for various cell types. Advanced BioMatrix plays a significant role in the global collagen market by providing reliable, research-grade collagen solutions for in vitro studies and biomedical applications. Cologenesis Healthcare Pvt. Ltd. is a leading biotechnology company specializing in collagen-based products for medical, dental, and surgical applications. The company offers a diverse portfolio, including collagen sheets such as Collograft L and Diacoll SB, collagen particles like Collofiber-MM, collagen gels including Nanocoll Gel and Gencoll Gel, as well as dental products and surgical aids like Collagen Coated Hernia Mesh. Cologenesis Healthcare has been actively involved in the collagen market, providing advanced, high-quality solutions that support tissue regeneration, wound healing, and surgical recovery, strengthening its presence in the markets. *Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
STERLING Biotech
Weishardt Holding SA
Advanced BioMatrix, Inc.
Cologenesis Healthcare Pvt. Ltd.
Other key players in the market are Collagen Solution LLC, Croda International Plc, Titan Biotech, and PAN-Biotech GmbH.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Source |
|
| Breakup by Product |
|
| Breakup by Application |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share